EUVIMEDEUVIMED entdecken
Crossref

DIAPH1 mutations predict a favorable outcome for de novo MDS

Yaqiong Tang, Hong Wang, Ziyan Zhang, Yifang Yao, Yue Han, Depei Wu

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Yaqiong Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suz…. Hauptthemen laut MEDLINE: Formins, Myelodysplastic Syndromes, Frameshift Mutation, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DIAPH1, a member of the formins family and a Rho effector, was found to be involved in thrombocytopoiesis, and the process of MDS in mice with unknown pathogenesis. In this study, we reported a preliminary study about the heterogeneity in the clinical features and outcomes of DIAPH1 mutations in MDS. DIAPH1 frameshift mutations were identified in 20 out of 88 MDS patients, including 11 frameshift mutations locating at 140892588-141000567 (5q31.3), which causes structure changes at FH1 domain. DIAPH1 mutated cases were correlated with lower megakaryocyte dysplasia in lower-risk patients (IPSS-M score

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ForminsMyelodysplastic SyndromesFrameshift MutationAdaptor Proteins, Signal TransducingHumansFemaleMaleMiddle AgedAgedPrognosisAdultMegakaryocytesNuclear ProteinsCarrier ProteinsAged, 80 and overMutation

Substanzen

ForminsDIAPH1 protein, humanAdaptor Proteins, Signal TransducingSETBP1 protein, humanNuclear ProteinsCarrier Proteins

Autor:innen und Institutionen

  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China; Institute of Blood and Marrow Transplantation, Collaborati…
  • Suzhou Hongci Hematology Hospital, Suzhou, China.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Science and Technology Bureau

Zitieren

APA

Tang, Y., Wang, H., Zhang, Z., Yao, Y., Han, Y., & Wu, D. (2024). DIAPH1 mutations predict a favorable outcome for de novo MDS. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217125

Vancouver

Tang Y, Wang H, Zhang Z, Yao Y, Han Y, Wu D. DIAPH1 mutations predict a favorable outcome for de novo MDS. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217125

BibTeX
@article{Tang2024,
  author = {Tang, Yaqiong and Wang, Hong and Zhang, Ziyan and Yao, Yifang and Han, Yue and Wu, Depei},
  title = {DIAPH1 mutations predict a favorable outcome for de novo MDS},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217125}
}
Kostenlos starten →